https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-16/ 2006-12-12T22:00:00+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-15/ 2007-04-15T23:00:00+01:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-14/ 2007-05-13T23:00:00+01:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-13/ 2007-08-15T23:00:00+01:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-12/ 2007-09-27T23:00:00+01:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-11/ 2009-05-13T23:00:00+01:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-10/ 2009-08-12T23:00:00+01:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-9/ 2009-10-06T23:00:00+01:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-8/ 2009-11-15T22:00:00+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-7/ 2009-12-21T22:00:00+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-6/ 2010-01-19T22:00:00+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-5/ 2010-03-18T22:00:00+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-4/ 2010-04-21T23:00:00+01:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-3/ 2010-08-15T23:00:00+01:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-2/ 2010-11-14T22:00:00+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research/ 2011-04-20T23:00:00+01:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-vara-research-gmbh/ 2011-08-16T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-wirtschaftssenatorin-cornelia-yzer-eroffnet-epigenomics-neue-firmenzentrale-in-berlin-schoneberg-2/ 2014-11-20T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-aktion-zur-darmkrebs-fruherkennung-von-epigenomics-und-dem-institut-fur-medizinische-diagnostik-im-rahmen-der-health-week-ein-voller-erfolg-2/ 2014-12-08T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2015-06-25T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2015-09-03T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-of-voting-rights-notifications-%c2%a7-21-para-1-wphg/ 2015-09-08T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2015-11-17T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2016-04-24T23:00:00+01:00 https://www.epigenomics.com/correction-of-a-release-from-25-04-2016-1827-cet-cest-epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-d/ 2016-04-25T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2016-06-06T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2016-06-06T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2016-06-06T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2016-06-06T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2016-06-07T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2016-06-16T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2016-06-20T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2016-07-06T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2016-07-10T23:00:00+01:00 https://www.epigenomics.com/correction-of-a-release-from-11-07-2016-1016-cet-cest-epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-d/ 2016-07-12T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2016-09-21T23:00:00+01:00 https://www.epigenomics.com/correction-of-a-release-from-22-09-2016-1138-cet-cest-epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-d/ 2016-10-23T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2016-11-23T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-systematische-wissenschaftliche-uberprufung-unterstreicht-nutzen-von-bluttest-epi-procolonr-bei-der-darmkrebserkennung-2/ 2017-01-29T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-systematic-study-review-supports-use-of-epi-procolonr-in-blood-based-cancer-detection/ 2017-01-29T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-04-10T23:00:00+01:00 https://www.epigenomics.com/correction-of-a-release-from-11-04-2017-1403-cet-cest-epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-d/ 2017-04-23T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-04-27T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-05-03T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-05-11T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-05-11T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-05-18T23:00:00+01:00 https://www.epigenomics.com/correction-of-a-release-from-19-05-2017-1258-cet-cest-epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-d/ 2017-05-21T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-05-30T23:00:00+01:00 https://www.epigenomics.com/epigenomics-annual-general-meeting-ceo-touts-takeover-offer-2/ 2017-05-30T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-hauptversammlung-ceo-wirbt-fur-ubernahmeangebot-2/ 2017-05-30T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-06-01T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-06-22T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-reduziert-prognose-fuer-das-geschaeftsjahr-2017/ 2017-07-06T22:16:14+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-07-10T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-07-10T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-07-12T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-07-13T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-07-23T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-07-25T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-08-22T23:00:00+01:00 https://www.epigenomics.com/original-research-epigenomics-ag-von-first-berlin-equity-research-gmbh-3/ 2017-10-05T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-10-15T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2017-10-18T23:00:00+01:00 https://www.epigenomics.com/original-research-epigenomics-ag-von-first-berlin-equity-research-gmbh-2/ 2017-12-18T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2018-01-21T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2018-01-21T22:00:00+00:00 https://www.epigenomics.com/correction-of-a-release-from-22-01-2018-1633-cet-cest-epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-d/ 2018-01-22T22:00:00+00:00 https://www.epigenomics.com/original-research-epigenomics-ag-von-first-berlin-equity-research-gmbh/ 2018-04-15T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2018-05-21T23:00:00+01:00 https://www.epigenomics.com/release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2018-10-30T22:00:00+00:00 https://www.epigenomics.com/release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2018-10-30T22:00:00+00:00 https://www.epigenomics.com/release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2018-11-04T22:00:00+00:00 https://www.epigenomics.com/release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2018-11-04T22:00:00+00:00 https://www.epigenomics.com/release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2018-11-04T22:00:00+00:00 https://www.epigenomics.com/release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2018-11-06T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2018-11-21T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-correction-of-a-release-from-27-11-2018-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2018-11-26T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2018-11-26T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2018-12-18T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2018-12-19T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-01-01T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-01-01T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-01-10T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-01-10T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-02-04T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-02-17T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-correction-of-a-release-from-31-10-2018-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-02-26T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-03-05T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-03-17T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-03-28T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-03-28T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-04-22T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-05-02T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-05-02T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-05-02T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-05-02T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-05-14T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-06-18T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-07-22T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-08-04T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-10-29T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-10-30T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-11-03T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-11-07T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-11-14T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-11-14T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-11-18T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-correction-of-a-release-from-15-11-2019-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2019-11-18T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2020-01-06T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2020-01-20T22:00:00+00:00 https://www.epigenomics.com/original-research-epigenomics-ag-von-first-berlin-equity-research-gmbh-4/ 2020-02-24T06:06:12+00:00 https://www.epigenomics.com/original-research-epigenomics-ag-von-first-berlin-equity-research-gmbh-5/ 2020-02-24T06:06:14+00:00 https://www.epigenomics.com/original-research-epigenomics-ag-von-first-berlin-equity-research-gmbh-6/ 2020-02-24T06:06:18+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-vara-research-gmbh-2/ 2020-02-24T06:11:05+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-17/ 2020-02-24T06:11:06+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-18/ 2020-02-24T06:11:09+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-19/ 2020-02-24T06:11:10+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-21/ 2020-02-24T06:11:12+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-20/ 2020-02-24T06:11:12+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-24/ 2020-02-24T06:11:14+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-23/ 2020-02-24T06:11:14+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-22/ 2020-02-24T06:11:14+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-25/ 2020-02-24T06:11:15+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-27/ 2020-02-24T06:11:16+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-26/ 2020-02-24T06:11:16+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-28/ 2020-02-24T06:11:17+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-30/ 2020-02-24T06:11:18+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-29/ 2020-02-24T06:11:18+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-32/ 2020-02-24T06:11:19+00:00 https://www.epigenomics.com/de/original-research-epigenomics-ag-von-midas-research-31/ 2020-02-24T06:11:19+00:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-20/ 2020-04-24T14:02:45+01:00 https://www.epigenomics.com/korrektur-der-veroffentlichung-vom-11-07-2016-1016-uhr-mez-mesz-epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:02:49+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-21/ 2020-04-24T14:02:51+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-22/ 2020-04-24T14:02:54+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-23/ 2020-04-24T14:02:57+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-24/ 2020-04-24T14:02:59+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-25/ 2020-04-24T14:03:01+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-26/ 2020-04-24T14:03:04+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-27/ 2020-04-24T14:03:06+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-28/ 2020-04-24T14:03:08+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-29/ 2020-04-24T14:03:11+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-5/ 2020-04-24T14:03:12+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-6/ 2020-04-24T14:03:14+01:00 https://www.epigenomics.com/korrektur-der-veroffentlichung-vom-25-04-2016-1827-uhr-mez-mesz-epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:03:17+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-30/ 2020-04-24T14:03:18+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-7/ 2020-04-24T14:03:21+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-8/ 2020-04-24T14:03:23+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-9/ 2020-04-24T14:03:24+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2020-04-24T14:03:26+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-10/ 2020-04-24T14:03:27+01:00 https://www.epigenomics.com/epigenomics-ag-release-of-voting-rights-notifications-%c2%a7-21-para-1-wphg/ 2020-04-24T14:03:29+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-2/ 2020-04-24T14:03:29+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-11/ 2020-04-24T14:03:31+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-12/ 2020-04-24T14:03:32+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-13/ 2020-04-24T14:03:34+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-3/ 2020-04-24T14:03:35+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-31/ 2020-04-24T14:03:36+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-14/ 2020-04-24T14:03:37+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-15/ 2020-04-24T14:03:39+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-32/ 2020-04-24T14:03:39+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-33/ 2020-04-24T14:03:41+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-16/ 2020-04-24T14:03:42+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-34/ 2020-04-24T14:03:43+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-35/ 2020-04-24T14:03:44+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-36/ 2020-04-24T14:03:44+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-38/ 2020-04-24T14:03:46+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-37/ 2020-04-24T14:03:46+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-17/ 2020-04-24T14:03:48+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-40/ 2020-04-24T14:03:49+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-39/ 2020-04-24T14:03:49+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-41/ 2020-04-24T14:03:51+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-18/ 2020-04-24T14:03:52+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-42/ 2020-04-24T14:03:55+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-19/ 2020-04-24T14:03:55+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-44/ 2020-04-24T14:03:57+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-43/ 2020-04-24T14:03:57+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-45/ 2020-04-24T14:03:58+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-20/ 2020-04-24T14:04:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-21/ 2020-04-24T14:04:02+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-22/ 2020-04-24T14:04:03+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-47/ 2020-04-24T14:04:05+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-46/ 2020-04-24T14:04:05+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-23/ 2020-04-24T14:04:08+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-24/ 2020-04-24T14:04:09+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-4/ 2020-04-24T14:30:23+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-13/ 2020-04-24T14:35:29+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-28/ 2020-04-24T14:35:29+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-29/ 2020-04-24T14:35:30+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-26/ 2020-04-24T14:35:30+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-41-wphg-mit-dem-ziel-der-europaweiten-verbreitung-3/ 2020-04-24T14:35:31+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-25/ 2020-04-24T14:35:32+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-27/ 2020-04-24T14:35:32+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2020-04-24T14:35:33+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-2/ 2020-04-24T14:35:33+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:35:34+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-3/ 2020-04-24T14:35:34+01:00 https://www.epigenomics.com/epigenomics-ag-korrektur-einer-veroffentlichung-vom-15-11-2019-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:35:35+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-2/ 2020-04-24T14:35:36+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-3/ 2020-04-24T14:35:37+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-41-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:35:38+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-4/ 2020-04-24T14:35:39+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-5/ 2020-04-24T14:35:40+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-4/ 2020-04-24T14:35:41+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-6/ 2020-04-24T14:35:42+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-5/ 2020-04-24T14:35:42+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-8/ 2020-04-24T14:35:43+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-7/ 2020-04-24T14:35:43+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-10/ 2020-04-24T14:35:44+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-9/ 2020-04-24T14:35:44+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-11/ 2020-04-24T14:35:45+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-12/ 2020-04-24T14:35:45+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-13/ 2020-04-24T14:35:46+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-14/ 2020-04-24T14:35:47+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-15/ 2020-04-24T14:35:48+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-16/ 2020-04-24T14:35:48+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-18/ 2020-04-24T14:35:49+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-17/ 2020-04-24T14:35:49+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-19/ 2020-04-24T14:35:51+01:00 https://www.epigenomics.com/epigenomics-ag-korrektur-einer-veroffentlichung-vom-31-10-2018-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:35:51+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-21/ 2020-04-24T14:35:52+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-20/ 2020-04-24T14:35:52+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-23/ 2020-04-24T14:35:53+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-22/ 2020-04-24T14:35:53+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-24/ 2020-04-24T14:35:54+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-6/ 2020-04-24T14:35:55+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-7/ 2020-04-24T14:35:57+01:00 https://www.epigenomics.com/epigenomics-ag-korrektur-einer-veroffentlichung-vom-27-11-2018-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:35:58+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-8/ 2020-04-24T14:35:59+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-9/ 2020-04-24T14:36:00+01:00 https://www.epigenomics.com/veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:36:01+01:00 https://www.epigenomics.com/veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-2/ 2020-04-24T14:36:02+01:00 https://www.epigenomics.com/veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-3/ 2020-04-24T14:36:03+01:00 https://www.epigenomics.com/veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-4/ 2020-04-24T14:36:04+01:00 https://www.epigenomics.com/veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-5/ 2020-04-24T14:36:05+01:00 https://www.epigenomics.com/veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-6/ 2020-04-24T14:36:06+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-41-wphg-mit-dem-ziel-der-europaweiten-verbreitung-2/ 2020-04-24T14:36:07+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-10/ 2020-04-24T14:36:08+01:00 https://www.epigenomics.com/korrektur-der-veroffentlichung-vom-22-01-2018-1633-uhr-mez-mesz-epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:36:09+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-11/ 2020-04-24T14:36:10+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-12/ 2020-04-24T14:36:11+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:36:12+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:36:13+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-2/ 2020-04-24T14:36:13+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-3/ 2020-04-24T14:36:15+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-4/ 2020-04-24T14:36:16+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-5/ 2020-04-24T14:36:17+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-6/ 2020-04-24T14:36:18+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-7/ 2020-04-24T14:36:19+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-8/ 2020-04-24T14:36:20+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-9/ 2020-04-24T14:36:21+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-10/ 2020-04-24T14:36:22+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-11/ 2020-04-24T14:36:23+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-12/ 2020-04-24T14:36:24+01:00 https://www.epigenomics.com/korrektur-der-veroffentlichung-vom-19-05-2017-1258-uhr-mez-mesz-epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:36:25+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-13/ 2020-04-24T14:36:26+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-14/ 2020-04-24T14:36:27+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-15/ 2020-04-24T14:36:28+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-16/ 2020-04-24T14:40:12+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-17/ 2020-04-24T14:40:14+01:00 https://www.epigenomics.com/korrektur-der-veroffentlichung-vom-11-04-2017-1403-uhr-mez-mesz-epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:40:15+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-18/ 2020-04-24T14:40:16+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-2/ 2020-04-24T14:40:18+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-3/ 2020-04-24T14:40:21+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-19/ 2020-04-24T14:45:12+01:00 https://www.epigenomics.com/de/korrektur-der-veroffentlichung-vom-22-09-2016-1138-uhr-mez-mesz-epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:45:20+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-20/ 2020-04-24T14:50:18+01:00 https://www.epigenomics.com/de/korrektur-der-veroffentlichung-vom-11-07-2016-1016-uhr-mez-mesz-epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:50:21+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-21/ 2020-04-24T14:50:23+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-22/ 2020-04-24T14:50:25+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-23/ 2020-04-24T14:50:27+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-24/ 2020-04-24T14:50:29+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-25/ 2020-04-24T14:50:30+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-26/ 2020-04-24T14:50:32+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-27/ 2020-04-24T14:50:33+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-28/ 2020-04-24T14:50:35+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-29/ 2020-04-24T14:55:18+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-5/ 2020-04-24T14:55:20+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-6/ 2020-04-24T14:55:21+01:00 https://www.epigenomics.com/de/korrektur-der-veroffentlichung-vom-25-04-2016-1827-uhr-mez-mesz-epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T14:55:22+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-30/ 2020-04-24T14:55:24+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-7/ 2020-04-24T14:55:25+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-8/ 2020-04-24T14:55:26+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-9/ 2020-04-24T14:55:27+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2020-04-24T14:55:28+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-of-voting-rights-notifications-%c2%a7-21-para-1-wphg/ 2020-04-24T14:55:29+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-10/ 2020-04-24T14:55:29+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-2/ 2020-04-24T14:55:30+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-11/ 2020-04-24T14:55:31+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-12/ 2020-04-24T14:55:32+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-26-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-3/ 2020-04-24T14:55:33+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-13/ 2020-04-24T14:55:33+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-31/ 2020-04-24T14:55:34+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-14/ 2020-04-24T14:55:35+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-32/ 2020-04-24T14:55:36+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-15/ 2020-04-24T14:55:36+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-33/ 2020-04-24T14:55:37+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-34/ 2020-04-24T14:55:38+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-16/ 2020-04-24T14:55:38+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-36/ 2020-04-24T14:55:39+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-35/ 2020-04-24T14:55:39+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-38/ 2020-04-24T14:55:40+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-37/ 2020-04-24T14:55:40+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-17/ 2020-04-24T14:55:41+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-40/ 2020-04-24T14:55:42+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-39/ 2020-04-24T14:55:42+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-41/ 2020-04-24T14:55:43+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-18/ 2020-04-24T14:55:44+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-42/ 2020-04-24T14:55:45+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-19/ 2020-04-24T14:55:45+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-44/ 2020-04-24T14:55:46+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-43/ 2020-04-24T14:55:46+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-45/ 2020-04-24T14:55:47+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-20/ 2020-04-24T14:55:48+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-21/ 2020-04-24T14:55:49+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-22/ 2020-04-24T14:55:50+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-46/ 2020-04-24T14:55:51+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-47/ 2020-04-24T14:55:52+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-23/ 2020-04-24T14:55:53+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-24/ 2020-04-24T14:55:54+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-13/ 2020-04-24T15:05:38+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-28/ 2020-04-24T15:05:39+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-29/ 2020-04-24T15:05:39+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-26/ 2020-04-24T15:05:40+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-25/ 2020-04-24T15:05:42+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-27/ 2020-04-24T15:05:42+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2020-04-24T15:05:43+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-2/ 2020-04-24T15:05:44+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-3/ 2020-04-24T15:05:45+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T15:05:45+01:00 https://www.epigenomics.com/de/epigenomics-ag-korrektur-einer-veroffentlichung-vom-15-11-2019-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T15:05:47+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-2/ 2020-04-24T15:05:48+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-3/ 2020-04-24T15:05:50+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-4/ 2020-04-24T15:05:53+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-5/ 2020-04-24T15:05:55+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-4/ 2020-04-24T15:05:56+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-5/ 2020-04-24T15:05:57+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-7/ 2020-04-24T15:05:58+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-6/ 2020-04-24T15:05:58+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-8/ 2020-04-24T15:05:59+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-10/ 2020-04-24T15:06:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-9/ 2020-04-24T15:06:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-11/ 2020-04-24T15:06:01+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-12/ 2020-04-24T15:06:02+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-14/ 2020-04-24T15:06:03+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-13/ 2020-04-24T15:06:03+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-15/ 2020-04-24T15:06:04+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-17/ 2020-04-24T15:06:05+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-16/ 2020-04-24T15:06:05+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-18/ 2020-04-24T15:06:06+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-19/ 2020-04-24T15:06:07+01:00 https://www.epigenomics.com/de/epigenomics-ag-korrektur-einer-veroffentlichung-vom-31-10-2018-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T15:06:07+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-20/ 2020-04-24T15:06:08+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-21/ 2020-04-24T15:06:09+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-22/ 2020-04-24T15:06:09+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-23/ 2020-04-24T15:06:10+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-24/ 2020-04-24T15:06:11+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-6/ 2020-04-24T15:06:12+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-7/ 2020-04-24T15:06:13+01:00 https://www.epigenomics.com/de/epigenomics-ag-korrektur-einer-veroffentlichung-vom-27-11-2018-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T15:06:14+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-8/ 2020-04-24T15:06:16+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-9/ 2020-04-24T15:06:17+01:00 https://www.epigenomics.com/de/veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T15:06:18+01:00 https://www.epigenomics.com/de/veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-2/ 2020-04-24T15:06:19+01:00 https://www.epigenomics.com/de/veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-3/ 2020-04-24T15:06:20+01:00 https://www.epigenomics.com/de/veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-4/ 2020-04-24T15:06:21+01:00 https://www.epigenomics.com/de/veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-5/ 2020-04-24T15:06:22+01:00 https://www.epigenomics.com/de/veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-6/ 2020-04-24T15:06:24+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-41-wphg-mit-dem-ziel-der-europaweiten-verbreitung-2/ 2020-04-24T15:06:25+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-10/ 2020-04-24T15:06:26+01:00 https://www.epigenomics.com/de/korrektur-der-veroffentlichung-vom-22-01-2018-1633-uhr-mez-mesz-epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T15:06:27+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-11/ 2020-04-24T15:06:28+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-12/ 2020-04-24T15:06:30+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T15:06:31+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-2/ 2020-04-24T15:06:32+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T15:06:33+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-3/ 2020-04-24T15:06:34+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-4/ 2020-04-24T15:06:35+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-5/ 2020-04-24T15:06:36+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-6/ 2020-04-24T15:10:19+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-7/ 2020-04-24T15:10:20+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-8/ 2020-04-24T15:10:21+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-9/ 2020-04-24T15:10:22+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-10/ 2020-04-24T15:10:23+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-11/ 2020-04-24T15:10:24+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-12/ 2020-04-24T15:10:26+01:00 https://www.epigenomics.com/de/korrektur-der-veroffentlichung-vom-19-05-2017-1258-uhr-mez-mesz-epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T15:10:28+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-13/ 2020-04-24T15:10:29+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-14/ 2020-04-24T15:10:31+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-15/ 2020-04-24T15:10:32+01:00 https://www.epigenomics.com/epigenomics-ag-successfully-completes-capital-increase-3/ 2020-04-24T15:10:33+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-16/ 2020-04-24T15:10:34+01:00 https://www.epigenomics.com/centers-for-medicare-medicaid-services-open-ncd-review-process-for-epi-procolon/ 2020-04-24T15:10:34+01:00 https://www.epigenomics.com/epigenomics-ag-decides-to-increase-share-capital-by-way-of-private-placement/ 2020-04-24T15:10:34+01:00 https://www.epigenomics.com/epigenomics-ag-sets-subscription-price-at-eur-1-11-per-new-share-2/ 2020-04-24T15:10:35+01:00 https://www.epigenomics.com/epigenomics-ag-successfully-completes-capital-increase-2/ 2020-04-24T15:10:35+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-17/ 2020-04-24T15:10:36+01:00 https://www.epigenomics.com/epigenomics-ag-chinese-patent-reexamination-department-partially-invalidates-epigenomics-patent-claims-for-septin9/ 2020-04-24T15:10:36+01:00 https://www.epigenomics.com/epigenomics-ag-decides-to-increase-share-capital-through-rights-issue-with-subscription-rights-of-existing-shareholders-2/ 2020-04-24T15:10:36+01:00 https://www.epigenomics.com/epigenomics-ag-terminates-collaboration-with-chinese-licensing-partner-and-announces-anticipated-revenue-growth-in-2019-outlook-2/ 2020-04-24T15:10:37+01:00 https://www.epigenomics.com/epigenomics-ag-cms-accepts-epigenomics-application-for-ncd-review-2/ 2020-04-24T15:10:37+01:00 https://www.epigenomics.com/epigenomics-ag-epigenomics-ag-sets-subscription-price-at-eur-1-86-per-new-share/ 2020-04-24T15:10:38+01:00 https://www.epigenomics.com/epigenomics-ag-successfully-completes-capital-increase-gross-proceeds-of-eur-22-3-million-2/ 2020-04-24T15:10:38+01:00 https://www.epigenomics.com/de/korrektur-der-veroffentlichung-vom-11-04-2017-1403-uhr-mez-mesz-epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T15:10:39+01:00 https://www.epigenomics.com/epigenomics-ag-centers-for-medicare-medicaid-services-publish-preliminary-rate-of-192-for-epigenomics-colorectal-cancer-screening-test-epi-procolonr/ 2020-04-24T15:10:39+01:00 https://www.epigenomics.com/epigenomics-ag-plans-to-increase-share-capital-with-subscription-rights-for-existing-shareholders-commitment-of-major-shareholder-to-participate-in-planned-capital-increase-2/ 2020-04-24T15:10:39+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-18/ 2020-04-24T15:10:40+01:00 https://www.epigenomics.com/epigenomics-ag-american-cancer-society-published-its-updated-colorectal-cancer-screening-guidelines-2/ 2020-04-24T15:10:40+01:00 https://www.epigenomics.com/epigenomics-ag-issues-new-shares-by-way-of-private-placement-4/ 2020-04-24T15:10:41+01:00 https://www.epigenomics.com/epigenomics-ag-notice-of-loss-pursuant-to-%c2%a7-92-par-1-aktg-4/ 2020-04-24T15:10:41+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-2/ 2020-04-24T15:10:42+01:00 https://www.epigenomics.com/epigenomics-ag-issues-change-in-guidance-for-financial-year-2017-2/ 2020-04-24T15:10:42+01:00 https://www.epigenomics.com/epigenomics-ag-notice-of-loss-pursuant-to-%c2%a7-92-par-1-aktg-5/ 2020-04-24T15:10:42+01:00 https://www.epigenomics.com/epigenomics-ag-issues-new-shares-by-way-of-private-placement-5/ 2020-04-24T15:10:43+01:00 https://www.epigenomics.com/epigenomics-ag-blitz-f16-83-gmbh-to-launch-takeover-offer-for-epigenomics-ag-2/ 2020-04-24T15:10:43+01:00 https://www.epigenomics.com/epigenomics-ag-issues-new-shares-by-way-of-private-placement-7/ 2020-04-24T15:10:44+01:00 https://www.epigenomics.com/supervisory-board-of-epigenomics-ag-appoints-gregory-hamilton-as-chief-executive-officer-ceo-3/ 2020-04-24T15:10:44+01:00 https://www.epigenomics.com/epigenomics-ag-issues-new-shares-by-way-of-private-placement-6/ 2020-04-24T15:10:44+01:00 https://www.epigenomics.com/epigenomics-ag-epigenomics-enters-strategic-license-and-development-agreement-with-biochain-on-novel-blood-based-lung-cancer-test-for-china/ 2020-04-24T15:10:45+01:00 https://www.epigenomics.com/epigenomics-receives-fda-approval-for-epi-procolonr/ 2020-04-24T15:10:45+01:00 https://www.epigenomics.com/epigenomics-ag-appeals-recent-fda-request-for-additional-information/ 2020-04-24T15:10:46+01:00 https://www.epigenomics.com/epigenomics-receives-fda-notification-about-status-of-pending-approval-decision-for-epi-procolonr/ 2020-04-24T15:10:46+01:00 https://www.epigenomics.com/epigenomics-ag-epigenomics-adjusts-2015-outlook-after-fda-response-letter/ 2020-04-24T15:10:47+01:00 https://www.epigenomics.com/epigenomics-ag-fda-requests-further-data-for-approval-of-epigenomics-blood-based-colorectal-cancer-screening-test-2/ 2020-04-24T15:10:47+01:00 https://www.epigenomics.com/epigenomics-reaches-99-5-adherence-for-epi-procolonr-in-admit-study-2/ 2020-04-24T15:10:48+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-sec-15-wphg-german-securities-trading-act-epigenomics-ag-announces-capital-increase-up-to-eur-5m/ 2020-04-24T15:10:48+01:00 https://www.epigenomics.com/epigenomics-ag-epigenomics-ag-places-maximum-number-of-new-shares-in-capital-increase-with-pre-emptive-rights/ 2020-04-24T15:10:48+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a7-15-wphg-german-securities-trading-act-fda-issues-response-letter-for-epigenomics-colorectal-cancer-screening-blood-test-epi-procolonr-requesting-further-d/ 2020-04-24T15:10:49+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a7-15-wphg-german-securities-trading-act-epigenomics-raises-usd-5-3-million-from-its-strategic-commercialization-partner-biochain/ 2020-04-24T15:10:49+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a7-15-wphg-german-securities-trading-act-epigenomics-and-biochain-announce-approval-of-epi-procolonr-in-china/ 2020-04-24T15:10:49+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a7-15-wphg-german-securities-trading-act-epigenomics-ag-fda-advisory-committee-provides-recommendations-for-epigenomics-colorectal-cancer-screening-blood-tes/ 2020-04-24T15:10:50+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a7-15-wphg-german-securities-trading-act-epigenomics-partner-biochain-successfully-completes-clinical-validation-study-for-cfda-approval-of-epi-procolonr-in/ 2020-04-24T15:10:50+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a7-15-wphg-german-securities-trading-act-epigenomics-ag-sets-conversion-price/ 2020-04-24T15:10:51+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a7-15-wphg-german-securities-trading-act-epigenomics-ag-announces-placement-of-maximal-amount-of-convertible-bonds/ 2020-04-24T15:10:51+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a7-15-wphg-german-securities-trading-act-epigenomics-ag-issues-eur-500000-in-convertible-bonds-to-yorkville/ 2020-04-24T15:10:52+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a7-15-wphg-german-securities-trading-act-epigenomics-ag-announces-fda-advisory-committee-meeting-to-review-epi-procolonr/ 2020-04-24T15:10:52+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a7-15-wphg-german-securities-trading-act-epigenomics-ag-issues-convertible-bonds-of-up-to-eur-2-68m/ 2020-04-24T15:10:52+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a715-wphg-german-securities-trading-act-epigenomics-ag-increases-share-capital/ 2020-04-24T15:10:53+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a715-wphg-german-securities-trading-act-epigenomics-ag-successfully-completes-private-placement-of-newly-issued-shares/ 2020-04-24T15:10:53+01:00 https://www.epigenomics.com/correction-notification-ad-hoc-announcement-pursuant-to-%c2%a715-wphg-german-securities-trading-act-correction-of-the-announcement-epigenomics-ag-increases-share-capital-2/ 2020-04-24T15:10:53+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a7-15-wphg-german-securities-trading-act-epigenomics-issues-new-shares-to-biochain-investment-follows-agreement-on-broad-strategic-collaboration-in-china/ 2020-04-24T15:10:54+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a7-15-wphg-german-securities-trading-act-epigenomics-and-biochain-sign-agreement-for-broad-strategic-collaboration-in-china/ 2020-04-24T15:10:54+01:00 https://www.epigenomics.com/epigenomics-ag-ad-hoc-announcement-pursuant-to-%c2%a7-15-wphg-german-securities-trading-act-epigenomics-ag-issues-eur-500000-in-convertible-bonds-to-ya-global-master-spv-ltd/ 2020-04-24T15:10:55+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a7-15-wphg-german-securities-trading-act-epigenomics-signs-joint-commercialization-agreement-for-epi-procolonr-in-north-america-with-polymedco/ 2020-04-24T15:10:55+01:00 https://www.epigenomics.com/ad-hoc-announcement-pursuant-to-%c2%a7-15-wphg-german-securities-trading-act-epigenomics-ag-secures-financing-of-up-to-eur-5m/ 2020-04-24T15:10:56+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-4/ 2020-04-24T15:15:11+01:00 https://www.epigenomics.com/korrektur-der-veroffentlichung-vom-22-09-2016-1138-uhr-mez-mesz-epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-04-24T15:15:15+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-26a-wphg-mit-dem-ziel-der-europaweiten-verbreitung-3/ 2020-04-24T15:15:19+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-26-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-19/ 2020-04-24T15:15:22+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-30/ 2020-04-26T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-30/ 2020-04-26T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-31/ 2020-04-27T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-31/ 2020-04-27T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-32/ 2020-05-04T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-32/ 2020-05-04T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-33/ 2020-05-05T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-33/ 2020-05-05T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-34/ 2020-05-24T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-34/ 2020-05-24T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-35/ 2020-06-15T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-35/ 2020-06-15T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-36/ 2020-06-30T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-36/ 2020-06-30T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-37/ 2020-07-01T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-37/ 2020-07-01T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-38/ 2020-07-02T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-38/ 2020-07-02T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-39/ 2020-07-05T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-39/ 2020-07-05T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-40/ 2020-07-06T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-40/ 2020-07-06T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-41/ 2020-07-14T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-41/ 2020-07-14T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-42/ 2020-07-15T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-42/ 2020-07-15T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-43/ 2020-07-20T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-43/ 2020-07-20T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-44/ 2020-07-22T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-44/ 2020-07-22T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-45/ 2020-07-28T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-45/ 2020-07-28T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-46/ 2020-07-30T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-46/ 2020-07-30T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-47/ 2020-07-30T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-47/ 2020-07-30T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-48/ 2020-08-05T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-48/ 2020-08-05T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-49/ 2020-08-09T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-49/ 2020-08-09T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-50/ 2020-08-12T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-50/ 2020-08-12T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-51/ 2020-08-12T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-51/ 2020-08-12T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-52/ 2020-09-01T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-52/ 2020-09-01T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-53/ 2020-09-08T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-53/ 2020-09-08T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-54/ 2020-09-10T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-54/ 2020-09-10T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-55/ 2020-09-22T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-56/ 2020-09-22T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-55/ 2020-09-22T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-56/ 2020-09-22T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-57/ 2020-09-24T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-58/ 2020-09-24T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-57/ 2020-09-24T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-58/ 2020-09-24T23:00:00+01:00 https://www.epigenomics.com/midas-research-expessnote-zur-epigenomics-ag-vorgeschlagene-kapitalzusammenlegung-sinnvoll-rein-formale-verlustanzeige-mit-anschliesender-kostentreibender-a-o-hv-werden-vermieden-kein-aktuell/ 2020-09-28T14:40:14+01:00 https://www.epigenomics.com/midas-research-expressnote-zur-epigenomics-ag-epigenomics-vergibt-forschungslizenz-und-kommerzialisierungsoption-fur-msept9-biomarker-an-qiagen/ 2020-09-28T14:40:15+01:00 https://www.epigenomics.com/midas-research-expessnote-zur-epigenomics-ag-partner-quest-diagnostics-erhalt-zulassung-fur-septin9-test-im-staat-new-york/ 2020-09-28T14:40:15+01:00 https://www.epigenomics.com/expressnote-epigenomics-bestatigt-vorsprung-bei-darmkrebs-diagnostik-auf-richtungsweisenden-kongressen/ 2020-09-28T14:40:16+01:00 https://www.epigenomics.com/expressnote-neues-personal-fur-neue-unternehmensphase-stabwechsel-im-finanzresort-von-epigenomics-planmasig-zum-31-3-2011/ 2020-09-28T14:40:16+01:00 https://www.epigenomics.com/expressnote-zur-epigenomics-ag-dr-thomas-taapken-als-kunftiger-cfo-uberzeugt-genauso-wie-epi-procolon-2-0/ 2020-09-28T14:40:16+01:00 https://www.epigenomics.com/midas-research-midas-research-expressnote-von-midas-research-zu-epigenomics-ag-isin-de000a0bvt96/ 2020-09-28T14:40:17+01:00 https://www.epigenomics.com/midas-research-expressnote-von-midas-research-zu-epigenomics-ag-isin-de000a0bvt96-3/ 2020-09-28T14:40:18+01:00 https://www.epigenomics.com/midas-research-expressnote-von-midas-research-zu-epigenomics-ag-isin-de000a0bvt96-2/ 2020-09-28T14:40:18+01:00 https://www.epigenomics.com/midas-research-expressnote-von-midas-research-zu-epigenomics-ag-isin-de000a0bvt96/ 2020-09-28T14:40:18+01:00 https://www.epigenomics.com/midas-research-expressenote-zu-epigenomics-ag-2/ 2020-09-28T14:40:19+01:00 https://www.epigenomics.com/midas-research-expressenote-zu-epigenomics-ag/ 2020-09-28T14:40:19+01:00 https://www.epigenomics.com/midas-research-expressenote-zu-epigenomics-ag-4/ 2020-09-28T14:40:20+01:00 https://www.epigenomics.com/midas-research-expressenote-zu-epigenomics-ag-3/ 2020-09-28T14:40:20+01:00 https://www.epigenomics.com/midas-research-expressnote-zu-epigenomics-ag/ 2020-09-28T14:40:21+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-59/ 2020-09-29T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-59/ 2020-09-29T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-60/ 2020-10-12T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-60/ 2020-10-12T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ecx-de-key-catalysts-to-fuel-growth-throughout-2019/ 2020-10-14T20:35:56+01:00 https://www.epigenomics.com/de/epigenomics-ecx-de-2018-results-highlight-strong-underlying-growth-momentum/ 2020-10-14T20:36:00+01:00 https://www.epigenomics.com/de/epigenomics-ecx-de-q3-milestone-completion-triggers-more-commercial-momentum/ 2020-10-14T20:36:10+01:00 https://www.epigenomics.com/de/epigenomics-ecx-de-strong-tailwinds-expected-from-epi-proliver/ 2020-10-14T20:36:15+01:00 https://www.epigenomics.com/de/epigenomics-ecx-de-liver-boost-less-dependency-on-epicolon/ 2020-10-14T20:36:18+01:00 https://www.epigenomics.com/epigenomics-ag-u-s-centers-for-medicare-medicaid-services-publish-negative-proposed-ncd-for-epi-procolon/ 2020-10-15T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-61/ 2020-10-25T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-61/ 2020-10-25T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-62/ 2020-10-25T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-62/ 2020-10-25T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-verlustanzeige-nach-%c2%a7-92-abs-1-aktg-6/ 2020-10-29T15:35:07+00:00 https://www.epigenomics.com/de/epigenomics-ag-staatliche-us-krankenversicherung-centers-for-mediacare-medicaid-services-arbeiten-aktiv-am-vorlaufigen-erstattungsvorschlag-mit-dem-ziel-einer-schnellstmoglichen-veroffentlichun/ 2020-10-29T15:35:08+00:00 https://www.epigenomics.com/de/epigenomics-ag-veranstaltet-telefonkonferenz-anlasslich-der-vorlaufigen-cms-erstattungsentscheidung/ 2020-10-29T15:35:08+00:00 https://www.epigenomics.com/de/epigenomics-ag-prasentiert-operative-highlights-und-veroffentlicht-finanzergebnisse-fur-die-ersten-sechs-monate-2020/ 2020-10-29T15:35:09+00:00 https://www.epigenomics.com/de/epigenomics-ag-nimmt-an-der-raymond-james-human-health-innovations-konferenz-teil/ 2020-10-29T15:35:10+00:00 https://www.epigenomics.com/de/neue-studie-im-journal-of-the-national-cancer-institute-zeigt-dass-epi-procolonr-der-bevorzugte-test-der-zahlreichen-patienten-ist-die-nicht-bereit-sind-am-darmkrebs-screening-per-fit-oder-darmsp/ 2020-10-29T15:35:10+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlicht-finanzergebnisse-fur-das-geschaftsjahr-2019-sowie-vorlaufige-ungeprufte-finanzergebnisse-fur-das-erste-quartal-2020/ 2020-10-29T15:35:11+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlicht-finanzergebnisse-fur-das-erste-quartal-2020/ 2020-10-29T15:35:11+00:00 https://www.epigenomics.com/de/epigenomics-ag-ergreift-umfassende-masnahmen-zur-kostensenkung-wahrend-der-covid-19-pandemie/ 2020-10-29T15:35:12+00:00 https://www.epigenomics.com/de/epigenomics-ag-epi-procolon-in-die-2020er-richtlinien-zur-darmkrebs-fruherkennung-des-national-comprehensive-cancer-network-aufgenommen/ 2020-10-29T15:35:12+00:00 https://www.epigenomics.com/de/epigenomics-gibt-die-verschiebung-der-hauptversammlung-aufgrund-des-coronavirus-und-vorlaufige-ungeprufte-finanzergebnisse-fur-2019-bekannt/ 2020-10-29T15:35:13+00:00 https://www.epigenomics.com/de/epigenomics-berichtet-uber-ergebnisse-einer-mikrosimulationsstudie-die-zeigen-dass-epi-procolon-eine-klinisch-signifikante-reduzierung-der-haufigkeit-und-mortalitat-von-darmkrebs-ermoglicht/ 2020-10-29T15:35:14+00:00 https://www.epigenomics.com/de/centers-for-medicare-medicaid-services-eroffnen-ncd-prufungsprozess-fur-epi-procolon-2/ 2020-10-29T15:35:14+00:00 https://www.epigenomics.com/de/epigenomics-ag-neue-mikrosimulationsstudie-zeigt-dass-epi-procolonr-eine-klinisch-signifikante-reduzierung-der-haufigkeit-und-mortalitat-von-darmkrebs-ermoglicht/ 2020-10-29T15:35:15+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlicht-finanzergebnisse-fur-die-ersten-neun-monate-2019/ 2020-10-29T15:35:16+00:00 https://www.epigenomics.com/de/epigenomics-ag-keine-operativen-grunde-fur-starken-kursruckgang/ 2020-10-29T15:35:17+00:00 https://www.epigenomics.com/de/epigenomics-ag-kundigt-telefonkonferenz-mit-den-autoren-des-mikrosimulationsmodells-im-rahmen-der-european-public-health-conference-an/ 2020-10-29T15:35:17+00:00 https://www.epigenomics.com/de/epigenomics-ag-ergebnisse-des-mikrosimulationsmodells-werden-auf-renommierter-health-conference-prasentiert/ 2020-10-29T15:35:18+00:00 https://www.epigenomics.com/de/neue-studie-empfiehlt-dass-nicht-invasive-screening-methoden-einschlieslich-epi-procolon-eine-kostengunstige-option-sein-konnen-um-die-offizielle-zielgrose-fur-die-us-amerikanische-darmkrebsvorsor/ 2020-10-29T15:35:19+00:00 https://www.epigenomics.com/de/epigenomics-ag-prasentiert-operative-highlights-und-veroffentlicht-finanzergebnisse-fur-die-ersten-sechs-monate-2019/ 2020-10-29T15:35:19+00:00 https://www.epigenomics.com/de/epigenomics-ag-neue-klinische-daten-unterstreichen-den-nutzen-des-epi-procolonr-bluttests-fur-die-darmkrebsvorsorge-bei-patienten-mit-lynchsyndrom/ 2020-10-29T15:35:20+00:00 https://www.epigenomics.com/de/epigenomics-ag-erhalt-den-medtech-outlook-2019-top-10-in-vitro-diagnostics-award/ 2020-10-29T15:35:20+00:00 https://www.epigenomics.com/de/epigenomics-ag-nimmt-an-der-raymond-james-life-sciences-and-medtech-konferenz-im-juni-teil-2/ 2020-10-29T15:35:21+00:00 https://www.epigenomics.com/de/epigenomics-ag-epi-procolonr-erhalt-exzellenz-in-der-molekulardiagnostik-award-2019/ 2020-10-29T15:35:22+00:00 https://www.epigenomics.com/de/epigenomics-ag-neuer-bericht-zeigt-steigende-darmkrebs-screening-raten-bei-einer-medizinisch-unterversorgten-bevolkerung-unter-nutzung-des-epi-procolon-bluttests/ 2020-10-29T15:35:22+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlicht-finanzergebnisse-fur-das-erste-quartal-2019/ 2020-10-29T15:35:23+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlicht-finanzergebnisse-fur-das-geschaftsjahr-2018/ 2020-10-29T15:35:24+00:00 https://www.epigenomics.com/de/epigenomics-ag-cms-akzeptiert-epigenomics-antrag-auf-ncd-uberprufung/ 2020-10-29T15:35:24+00:00 https://www.epigenomics.com/de/korrektur-der-corporate-news-vom-15-03-2019-1240-uhr-epigenomics-ag-%e2%80%8bus-kongressmitglieder-payne-und-marchant-fuhren-uberparteilichen-gesetzesentwurf-zur-darmkrebserkennung-ein/ 2020-10-29T15:35:25+00:00 https://www.epigenomics.com/de/epigenomics-ag-%e2%80%8bus-kongressmitglieder-payne-und-marchant-fuhren-uberparteilichen-gesetzesentwurf-zur-darmkrebserkennung-ein/ 2020-10-29T15:35:26+00:00 https://www.epigenomics.com/de/epigenomics-ag-gibt-den-beginn-einer-prospektiven-klinischen-studie-zur-erkennung-von-leberkrebs-bekannt-2/ 2020-10-29T15:35:27+00:00 https://www.epigenomics.com/de/epigenomics-ag-gibt-positive-ergebnisse-eines-mikrosimulationsmodells-bekannt-2/ 2020-10-29T15:35:27+00:00 https://www.epigenomics.com/de/centers-for-medicare-medicaid-services-veroffentlichen-offiziellen-gebuhrenkatalog-fur-klinische-laborleistungen-2019-inklusive-epi-procolonr/ 2020-10-29T15:35:28+00:00 https://www.epigenomics.com/de/epigenomics-ag-u-s-department-of-veterans-affairs-beginnt-studie-zum-darmkrebs-screening-mit-epigenomics-bluttest-epi-procolonr/ 2020-10-29T15:35:29+00:00 https://www.epigenomics.com/de/epigenomics-ag-gibt-finanzergebnisse-fur-das-dritte-quartal-und-die-ersten-neun-monate-2018-bekannt%e2%80%8b/ 2020-10-29T15:35:29+00:00 https://www.epigenomics.com/de/epigenomics-ag-centers-for-medicare-medicaid-services-cms-veroffentlichen-finale-kataloggebuhr-von-usd-192-fur-epigenomics-darmkrebs-test-epi-procolonr/ 2020-10-29T15:35:30+00:00 https://www.epigenomics.com/de/epigenomics-ag-erhalt-ce-kennzeichnung-fur-bluttest-zur-erkennung-von-leberkrebs/ 2020-10-29T15:35:30+00:00 https://www.epigenomics.com/de/epigenomics-ag-beschliest-kapitalerhohung-mit-bezugsrecht-der-aktionare/ 2020-10-29T15:35:31+00:00 https://www.epigenomics.com/de/epigenomics-ag-gibt-finanzergebnisse-fur-das-zweite-quartal-und-die-ersten-sechs-monate-2018-bekannt/ 2020-10-29T15:35:32+00:00 https://www.epigenomics.com/de/epigenomics-ag-us-kongress-dringt-auf-cms-erstattung-fur-bluttests-zum-darmkrebs-screening/ 2020-10-29T15:35:32+00:00 https://www.epigenomics.com/de/epigenomics-ag-ce-kennzeichnung-fur-bluttest-zur-erkennung-von-leberkrebs-geplant/ 2020-10-29T15:35:33+00:00 https://www.epigenomics.com/de/epigenomics-ag-gibt-finanzergebnisse-fur-das-erste-quartal-2018-bekannt/ 2020-10-29T15:35:34+00:00 https://www.epigenomics.com/de/epigenomics-ag-centers-for-medicare-medicaid-services-cms-veroffentlichen-vorlaufige-kataloggebuhr-fur-epigenomics-darmkrebs-test-epi-procolonr/ 2020-10-29T15:35:34+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlicht-finanzergebnisse-fur-das-geschaftsjahr-2017/ 2020-10-29T15:35:35+00:00 https://www.epigenomics.com/de/epigenomics-ag-bluttest-mit-uberzeugenden-klinischen-ergebnissen-bei-der-erkennung-von-leberkrebs/ 2020-10-29T15:35:35+00:00 https://www.epigenomics.com/de/senatoren-capito-und-heinrich-legen-dem-us-senat-uberparteilichen-gesetzentwurf-zur-darmkrebsvorsorge-vor/ 2020-10-29T15:35:36+00:00 https://www.epigenomics.com/de/aufsichtsrat-der-epigenomics-ag-ernennt-albert-weber-zum-executive-vice-president-finance-und-mitglied-des-vorstands-2/ 2020-10-29T15:35:37+00:00 https://www.epigenomics.com/de/epigenomics-ag-erhalt-ce-kennzeichnung-fur-lungenkrebstest-epi-prolungr/ 2020-10-29T15:35:37+00:00 https://www.epigenomics.com/de/epigenomics-ag-gibt-finanzergebnisse-fur-das-dritte-quartal-und-die-ersten-neun-monate-2017-bekannt/ 2020-10-29T15:35:38+00:00 https://www.epigenomics.com/de/epigenomics-ag-verkundet-cms-entscheidung-zum-erstattungspreis/ 2020-10-29T15:35:38+00:00 https://www.epigenomics.com/de/aufsichtsrat-der-epigenomics-ag-ernennt-dr-jorge-garces-zum-president-chief-scientific-officer-2/ 2020-10-29T15:35:39+00:00 https://www.epigenomics.com/de/epigenomics-ag-ernennt-director-reimbursement-medical-affairs-2/ 2020-10-29T15:35:39+00:00 https://www.epigenomics.com/de/epigenomics-beginnt-post-marketing-studie-mit-epi-procolonr/ 2020-10-29T15:35:40+00:00 https://www.epigenomics.com/de/epigenomics-ag-begibt-wandelschuldverschreibungen-2/ 2020-10-29T15:35:40+00:00 https://www.epigenomics.com/de/epigenomics-ag-freiwilliges-offentliches-ubernahmeangebot-der-summit-hero-holding-gmbh-nicht-erfolgreich/ 2020-10-29T15:35:41+00:00 https://www.epigenomics.com/de/epigenomics-ag-gibt-finanzergebnisse-fur-das-zweite-quartal-und-die-ersten-sechs-monate-2017-bekannt/ 2020-10-29T15:35:41+00:00 https://www.epigenomics.com/de/epigenomics-ag-angebotsunterlage-zum-freiwilligen-offentlichen-ubernahmeangebot-fur-die-epigenomics-ag-veroffentlicht/ 2020-10-29T15:35:42+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlicht-finanzergebnisse-fur-das-geschaftsjahr-2016-2/ 2020-10-29T15:35:43+00:00 https://www.epigenomics.com/de/epigenomics-ag-gibt-finanzergebnisse-fur-das-erste-quartal-2017-bekannt/ 2020-10-29T15:35:43+00:00 https://www.epigenomics.com/de/epigenomics-ag-u-s-department-of-veterans-affairs-erteilt-lieferauftrag-fur-epi-procolonr/ 2020-10-29T15:35:44+00:00 https://www.epigenomics.com/de/epigenomics-ag-blitz-f16-83-gmbh-plant-ubernahmeangebot-fur-epigenomics-ag/ 2020-10-29T15:35:44+00:00 https://www.epigenomics.com/de/epigenomics-ag-journal-of-molecular-diagnosis-therapy-veroffentlicht-publikation-zu-bluttest-epi-procolonr-2-0-ce/ 2020-10-29T15:35:45+00:00 https://www.epigenomics.com/de/epigenomics-beteiligt-sich-an-nationaler-initiative-zur-darmkrebsvorsorge-in-den-usa-2/ 2020-10-29T15:35:45+00:00 https://www.epigenomics.com/de/epigenomics-ag-kundigt-teilnahme-an-investorenkonferenzen-an/ 2020-10-29T15:35:46+00:00 https://www.epigenomics.com/de/epigenomics-ag-medizinjournal-cancer-treatment-and-research-communications-veroffentlicht-studienergebnisse-mit-bluttest-epi-procolonr/ 2020-10-29T15:35:46+00:00 https://www.epigenomics.com/de/epigenomics-ag-labornetzwerk-arup-laboratories-beginnt-mit-der-vermarktung-von-epigenomics-bluttest-zum-darmkrebs-screening-epi-procolonr/ 2020-10-29T15:35:47+00:00 https://www.epigenomics.com/de/epigenomics-ag-gibt-finanzergebnisse-fur-das-dritte-quartal-und-die-ersten-neun-monate-2016-bekannt-und-berichtet-uber-operative-fortschritte/ 2020-10-29T15:35:47+00:00 https://www.epigenomics.com/de/us-kongressmitglied-donald-m-payne-jr-stellt-uberparteiliche-gesetzesinitiative-zur-darmkrebsvorsorge-vor/ 2020-10-29T15:35:48+00:00 https://www.epigenomics.com/de/epigenomics-ag-journal-of-the-american-medical-association-jama-veroffentlicht-schreiben-zur-klarstellung-klinischer-daten-von-epi-procolonr/ 2020-10-29T15:35:48+00:00 https://www.epigenomics.com/de/epigenomics-ag-gibt-finanzergebnisse-fur-das-zweite-quartal-und-die-ersten-sechs-monate-2016-bekannt-und-berichtet-uber-operative-fortschritte/ 2020-10-29T15:35:49+00:00 https://www.epigenomics.com/de/epigenomics-ag-ubermittelt-entwurf-eines-registrierungsdokuments-fur-ein-mogliches-offentliches-angebot-von-american-depository-shares-in-den-usa-auf-vertraulicher-basis-an-sec/ 2020-10-29T15:35:49+00:00 https://www.epigenomics.com/de/epigenomics-ag-gibt-finanzergebnisse-fur-das-erste-quartal-2016-bekannt-und-berichtet-uber-operative-fortschritte/ 2020-10-29T15:35:50+00:00 https://www.epigenomics.com/de/uspstf-nimmt-epigenomics-bluttest-epi-procolonr-in-empfehlungen-zur-darmkrebsvorsorge-auf/ 2020-10-29T15:35:50+00:00 https://www.epigenomics.com/de/epigenomics-ag-chinesische-fda-kurt-septin9-bluttest-zu-einem-der-innovativsten-medizinprodukte-2015/ 2020-10-29T15:35:51+00:00 https://www.epigenomics.com/de/fuhrendes-us-labornetzwerk-labcorp-beginnt-mit-der-vermarktung-von-epigenomics-bluttest-zum-darmkrebs-screening-epi-procolonr-test-ab-sofort-landesweit-verfugbar/ 2020-10-29T15:35:51+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-prasentiert-daten-des-neuartigen-bluttests-zur-erkennung-von-lungenkrebs-auf-der-aacr-konferenz-2016/ 2020-10-29T15:35:52+00:00 https://www.epigenomics.com/de/epigenomics-startet-produktverkauf-von-epi-procolonr-in-den-usa/ 2020-10-29T15:35:52+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlicht-finanzergebnisse-fur-das-geschaftsjahr-2015-und-gibt-ausblick-auf-das-jahr-2016/ 2020-10-29T15:35:53+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-schliest-strategische-lizenz-und-entwicklungsvereinbarung-mit-biochain-fur-innovativen-blutbasierten-lungenkrebstest-ab/ 2020-10-29T15:35:53+00:00 https://www.epigenomics.com/de/epigenomics-ag-gibt-finanzergebnisse-fur-das-dritte-quartal-und-die-ersten-neun-monate-2015-bekannt-und-berichtet-uber-operative-fortschritte/ 2020-10-29T15:35:54+00:00 https://www.epigenomics.com/de/epigenomics-ag-glaubigerversammlung-zur-wandelanleihe-2013-beschliest-anderung-der-anleihebedingungen/ 2020-10-29T15:35:54+00:00 https://www.epigenomics.com/de/epigenomics-ag-fda-fordert-weitere-daten-vor-zulassung-von-epigenomics-bluttest-zum-darmkrebs-screening/ 2020-10-29T15:35:55+00:00 https://www.epigenomics.com/de/epigenomics-ag-innovatives-portfolio-blutbasierter-dna-methylierungs-biomarker-zeigt-vielversprechende-ergebnisse-bei-der-diagnose-von-lungenkrebs-2/ 2020-10-29T15:35:55+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-gibt-finanzergebnisse-fur-das-zweite-quartal-und-die-ersten-sechs-monate-2015-bekannt-und-berichtet-uber-operative-fortschritte/ 2020-10-29T15:35:56+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-gibt-ein-update-uber-bluttests-zur-krebsfruherkennung-auf-der-jahrestagung-2015-der-vereinigung-der-molekularpathologen-amp-in-den-usa/ 2020-10-29T15:35:56+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-und-biochain-geben-die-aufnahme-ihres-unternehmenseigenen-septin9-basierten-bluttests-in-die-chinesische-richtlinie-zum-darmkrebs-screening-bekannt/ 2020-10-29T15:35:57+00:00 https://www.epigenomics.com/de/epigenomics-ag-gibt-finanzergebnisse-fur-das-erste-quartal-2015-bekannt-und-berichtet-uber-operative-fortschritte/ 2020-10-29T15:35:58+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-schliest-kapitalerhohung-erfolgreich-ab/ 2020-10-29T15:35:58+00:00 https://www.epigenomics.com/de/epigenomics-erhalt-eu-forderung-in-hohe-von-eur-28-millionen-zur-validierung-seines-lungenkrebs-biomarkers-in-blutplasma/ 2020-10-29T15:35:59+00:00 https://www.epigenomics.com/de/epigenomics-epi-procolonr-erreicht-in-admit-studie-eine-teilnehmerrate-von-995/ 2020-10-29T15:35:59+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-veroffentlicht-finanzergebnisse-fur-geschaftsjahr-2014-und-gibt-ausblick-auf-das-jahr-2015/ 2020-10-29T15:36:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-gibt-abschluss-der-probandenrekrutierung-fur-admit-studie-mit-epi-procolonr-bekannt/ 2020-10-29T15:36:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-einschluss-der-ersten-patienten-in-epigenomics-admit-studie-mit-epi-procolonr/ 2020-10-29T15:36:01+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-und-biochain-geben-zulassung-von-epi-procolonr-in-china-bekannt/ 2020-10-29T15:36:02+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-prasentiert-auf-der-oppenheimer-25th-annual-healthcare-conference/ 2020-10-29T15:36:02+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-strategischer-kommerzialisierungspartner-polymedco-bekraftigt-seine-unterstutzung-von-epi-procolonr-in-den-usa/ 2020-10-29T15:36:03+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-gibt-finanzergebnisse-fur-das-dritte-quartal-und-die-ersten-neun-monate-2014-bekannt-und-berichtet-uber-operative-fortschritte/ 2020-10-29T15:36:03+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-fuhrt-kapitalerhohung-in-hohe-von-usd-53-mio-mit-ihrem-strategischen-vertriebspartner-biochain-durch/ 2020-10-29T15:36:04+00:00 https://www.epigenomics.com/de/epigenomics-ag-in-bmc-gastroenterology-veroffentlichte-studienergebnisse-belegen-erhohte-akzeptanz-eines-darmkrebs-screenings-durch-epigenomics-blutbasierten-test-epi-procolonr/ 2020-10-29T15:36:04+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-stellt-auf-namensaktien-um/ 2020-10-29T15:36:05+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-gibt-update-zur-unternehmensentwicklung/ 2020-10-29T15:36:05+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-gibt-finanzergebnisse-des-zweiten-quartals-und-des-ersten-halbjahres-2014-bekannt-und-berichtet-uber-operative-fortschritte/ 2020-10-29T15:36:06+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-gibt-die-veroffentlichung-der-ergebnisse-von-zwei-klinischen-studien-in-den-usa-mit-ihrem-blutbasierten-darmkrebstest-epi-procolonr-bekannt/ 2020-10-29T15:36:07+00:00 https://www.epigenomics.com/de/epigenomics-ag-gibt-update-zum-zulassungsprozess-und-informationen-zu-einer-weiteren-klinischen-studie-fur-epi-procolonr-in-den-usa/ 2020-10-29T15:36:07+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-erhalt-antwortschreiben-von-der-fda-zu-ihrem-blutbasierten-test-zur-fruherkennung-von-darmkrebs-epi-procolonr-in-dem-weitere-daten-vor-einer-zulassung-gefordert-werden/ 2020-10-29T15:40:03+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-gibt-finanzergebnisse-fur-das-erste-quartal-2014-bekannt-und-berichtet-uber-operative-fortschritte/ 2020-10-29T15:40:04+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-gibt-update-zum-status-des-zulassungsprozesses-fur-epi-procolonr-in-den-usa/ 2020-10-29T15:40:05+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-partner-biochain-schliest-klinische-validierungsstudie-zur-cfda-zulassung-von-epi-procolonr-in-china-erfolgreich-ab/ 2020-10-29T15:40:06+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-veroffentlicht-geschaftsbericht-2013-und-gibt-ausblick-auf-das-jahr-2014/ 2020-10-29T15:40:07+00:00 https://www.epigenomics.com/de/epigenomics-ag-fda-expertengremium-gibt-empfehlung-fur-epigenomics-blutbasierten-test-zur-fruherkennung-von-darmkrebs/ 2020-10-29T15:40:08+00:00 https://www.epigenomics.com/de/epigenomics-und-vsa-erhalten-marktzulassung-fur-epi-procolon-in-argentinien/ 2020-10-29T15:40:09+00:00 https://www.epigenomics.com/de/epigenomics-ag-ag-in-der-tschechischen-republik-durchgefuhrte-klinische-studie-belegt-dass-blutbasierte-septin9-tests-eine-attraktive-alternative-zur-darmkrebs-fruherkennung-darstellen/ 2020-10-29T15:40:10+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-berichtet-vorlaufige-finanzergebnisse-und-highlights-des-geschaftsjahres-2013/ 2020-10-29T15:40:11+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-erweitert-und-starkt-patentschutz-fur-epi-procolon-in-den-usa-und-china/ 2020-10-29T15:40:12+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-startet-handel-auf-dem-us-amerikanischen-otcqx-markt/ 2020-10-29T15:40:13+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-gibt-datum-fur-die-einberufung-des-fda-expertengremiums-zu-epi-procolon-und-fur-die-veroffentlichung-der-vorlaufigen-finanzergebnisse-2013-bekannt/ 2020-10-29T15:40:13+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-und-kindstar-unterzeichnen-lizenz-und-liefervereinbarung-fur-epi-prolung-test-in-china/ 2020-10-29T15:40:14+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-begrust-kostenerstattung-des-septin9-bluttests-durch-franzosische-krankenversicherung/ 2020-10-29T15:40:15+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-sichert-zusatzliche-finanzierung/ 2020-10-29T15:40:16+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-gibt-einberufung-des-expertengremiums-der-fda-zu-epi-procolonr-bekannt/ 2020-10-29T15:45:03+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-dna-methylierungs-biomarker-shox2-zeigt-vielversprechende-ergebnisse-bei-der-therapieuberwachung-von-lungenkrebspatienten/ 2020-10-29T15:45:04+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-gibt-finanzergebnisse-fur-das-dritte-quartal-und-die-ersten-neun-monate-2013-bekannt-und-berichtet-uber-operative-fortschritte/ 2020-10-29T15:45:05+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-und-biochain-vereinbaren-umfangreiche-strategische-zusammenarbeit-in-china-und-investment-in-epigenomics/ 2020-10-29T15:45:06+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-sichert-finanzierung-von-bis-zu-eur-5-mio/ 2020-10-29T15:45:07+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-und-polymedco-unterzeichnen-kommerzialisierungsvereinbarung-fur-epi-procolonr-fur-den-nordamerikanischen-markt/ 2020-10-29T15:45:07+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-gibt-finanzergebnisse-des-ersten-halbjahres-und-zweiten-quartals-2013-bekannt-und-berichtet-uber-operative-fortschritte/ 2020-10-29T15:45:08+00:00 https://www.epigenomics.com/de/epigenomics-us-studie-zeigt-potenzial-fur-blutbasierte-darmkrebs-fruherkennung-mit-septin9-um-leben-zu-retten-und-einen-gesundheitsokonomischen-nutzen-zu-bringen/ 2020-10-29T15:45:09+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-startet-american-depositary-receipt-adr-programm/ 2020-10-29T15:45:10+00:00 https://www.epigenomics.com/de/epigenomics-ag-ergebnisse-der-vergleichsstudie-zwischen-epigenomics-epi-procolonr-und-fit-werden-auf-der-digestive-disease-week-vorgestellt/ 2020-10-29T15:45:11+00:00 https://www.epigenomics.com/de/midas-research-expessnote-zur-epigenomics-ag-vorgeschlagene-kapitalzusammenlegung-sinnvoll-rein-formale-verlustanzeige-mit-anschliesender-kostentreibender-a-o-hv-werden-vermieden-kein-aktuell/ 2020-10-29T15:45:12+00:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-veroffentlicht-finanzergebnisse-fur-das-erste-quartal-2013-und-berichtet-uber-operative-fortschritte/ 2020-10-29T15:45:12+00:00 https://www.epigenomics.com/de/midas-research-expressnote-zur-epigenomics-ag-epigenomics-vergibt-forschungslizenz-und-kommerzialisierungsoption-fur-msept9-biomarker-an-qiagen/ 2020-10-29T15:45:13+00:00 https://www.epigenomics.com/de/midas-research-expessnote-zur-epigenomics-ag-partner-quest-diagnostics-erhalt-zulassung-fur-septin9-test-im-staat-new-york/ 2020-10-29T15:45:13+00:00 https://www.epigenomics.com/de/expressnote-neues-personal-fur-neue-unternehmensphase-stabwechsel-im-finanzresort-von-epigenomics-planmasig-zum-31-3-2011/ 2020-10-29T15:45:14+00:00 https://www.epigenomics.com/de/expressnote-zur-epigenomics-ag-dr-thomas-taapken-als-kunftiger-cfo-uberzeugt-genauso-wie-epi-procolon-2-0/ 2020-10-29T15:45:14+00:00 https://www.epigenomics.com/de/midas-research-midas-research-expressnote-von-midas-research-zu-epigenomics-ag-isin-de000a0bvt96/ 2020-10-29T15:45:15+00:00 https://www.epigenomics.com/de/expressnote-epigenomics-bestatigt-vorsprung-bei-darmkrebs-diagnostik-auf-richtungsweisenden-kongressen/ 2020-10-29T15:45:15+00:00 https://www.epigenomics.com/de/midas-research-expressnote-von-midas-research-zu-epigenomics-ag-isin-de000a0bvt96-2/ 2020-10-29T15:45:16+00:00 https://www.epigenomics.com/de/midas-research-expressnote-von-midas-research-zu-epigenomics-ag-isin-de000a0bvt96/ 2020-10-29T15:45:16+00:00 https://www.epigenomics.com/de/midas-research-expressenote-zu-epigenomics-ag/ 2020-10-29T15:45:17+00:00 https://www.epigenomics.com/de/midas-research-expressnote-von-midas-research-zu-epigenomics-ag-isin-de000a0bvt96-3/ 2020-10-29T15:45:17+00:00 https://www.epigenomics.com/de/midas-research-expressenote-zu-epigenomics-ag-3/ 2020-10-29T15:45:18+00:00 https://www.epigenomics.com/de/midas-research-expressenote-zu-epigenomics-ag-2/ 2020-10-29T15:45:18+00:00 https://www.epigenomics.com/de/midas-research-expressnote-zu-epigenomics-ag/ 2020-10-29T15:45:19+00:00 https://www.epigenomics.com/de/midas-research-expressenote-zu-epigenomics-ag-4/ 2020-10-29T15:45:19+00:00 https://www.epigenomics.com/epigenomics-ag-capital-reduction-and-further-authorization-to-issue-convertible-bonds-with-backstop-investor-planned/ 2020-11-02T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlicht-finanzergebnisse-fur-die-ersten-neun-monate-2020/ 2020-11-11T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2020-12-03T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroeffentlichung-gemaess-%c2%a7-50-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-12-09T10:28:38+00:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2020-12-09T10:43:17+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-41-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2020-12-09T10:47:25+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-der-gesamtzahl-der-stimmrechte-nach-%c2%a7-41-wphg-mit-dem-ziel-der-europaweiten-verbreitung-3/ 2020-12-09T10:48:14+00:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-63/ 2021-01-06T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-63/ 2021-01-06T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-issues-mandatory-convertible-bond-in-the-amount-of-up-to-eur-5-5-million/ 2021-01-06T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-14/ 2021-01-18T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-14/ 2021-01-18T22:00:00+00:00 https://www.epigenomics.com/u-s-centers-for-medicare-medicaid-services-publish-negative-ncd-for-epi-procolon/ 2021-01-18T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-korrektur-einer-veroffentlichung-vom-19-01-2021-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2021-01-19T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-korrektur-einer-veroffentlichung-vom-19-01-2021-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung/ 2021-01-19T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-plant-die-ncd-erstattungsentscheidung-anzufechten-und-stellt-ihren-bluttest-der-nachsten-generation-fur-die-darmkrebs-fruherkennung-vor/ 2021-01-20T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-15/ 2021-01-25T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-15/ 2021-01-25T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-successfully-places-mandatory-convertible-bond-in-the-full-amount-of-eur-5-5-million/ 2021-01-26T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-dr-jorge-garces-wird-berater-der-gesellschaft/ 2021-01-27T14:18:33+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-64/ 2021-01-31T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-64/ 2021-01-31T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-16/ 2021-02-02T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-17/ 2021-02-02T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-16/ 2021-02-02T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-17/ 2021-02-02T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-65/ 2021-02-03T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-65/ 2021-02-03T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-correction-of-a-release-from-04-02-2021-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2021-02-04T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-correction-of-a-release-from-04-02-2021-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2021-02-04T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-correction-of-a-release-from-05-02-2021-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2021-02-08T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-correction-of-a-release-from-05-02-2021-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2021-02-08T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-18/ 2021-02-08T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-18/ 2021-02-08T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-19/ 2021-02-09T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-19/ 2021-02-09T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-66/ 2021-02-24T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-66/ 2021-02-24T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-20/ 2021-03-01T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-20/ 2021-03-01T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-21/ 2021-03-16T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-21/ 2021-03-16T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-is-evaluating-ma-options/ 2021-03-24T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlicht-finanzergebnisse-fur-das-geschaftsjahr-2020/ 2021-03-24T22:00:00+00:00 https://www.epigenomics.com/de/eine-im-bmc-gastroenterology-veroffentlichte-studie-zeigt-deutlich-bessere-leistungsmerkmale-bei-epigenomics-leberkrebs-panel-als-der-aktuelle-fruherkennungsstandard-von-hepatozellularen-karzinomen/ 2021-04-05T23:00:00+01:00 https://www.epigenomics.com/de/%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8bepigenomics-ag-gibt-wandlungsergebnis-des-ersten-wandlungszeitraums-der-pflichtwandelanleihe-2021-2024-bekannt/ 2021-04-19T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-2/ 2021-04-19T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-22/ 2021-04-21T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-22/ 2021-04-21T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-23/ 2021-04-21T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-23/ 2021-04-21T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-68/ 2021-04-22T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-69/ 2021-04-22T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-68/ 2021-04-22T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-69/ 2021-04-22T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-67/ 2021-04-25T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-67/ 2021-04-25T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-beschliest-kapitalerhohung-mit-bezugsrecht-der-aktionare-3/ 2021-04-26T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-decides-to-increase-share-capital-through-rights-issue-with-subscription-rights-of-existing-shareholders-4/ 2021-04-26T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-24/ 2021-04-29T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-24/ 2021-04-29T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlicht-finanzergebnisse-fur-das-erste-quartal-2021/ 2021-05-11T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-successfully-completes-capital-increase-4/ 2021-05-17T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-3/ 2021-05-20T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-70/ 2021-05-24T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-70/ 2021-05-24T23:00:00+01:00 https://www.epigenomics.com/correction-of-a-release-from-21-05-2021-1434-cet-cest-epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution/ 2021-05-24T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-25/ 2021-05-26T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-25/ 2021-05-26T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-26/ 2021-05-26T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-71/ 2021-05-26T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-72/ 2021-05-26T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-26/ 2021-05-26T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-71/ 2021-05-26T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-72/ 2021-05-26T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-plans-to-issue-mandatory-convertible-bond-in-the-amount-of-up-to-eur-18-15-million/ 2021-06-10T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-73/ 2021-06-15T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-73/ 2021-06-15T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-27/ 2021-06-20T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-27/ 2021-06-20T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-28/ 2021-06-24T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-28/ 2021-06-24T23:00:00+01:00 https://www.epigenomics.com/release-according-to-article-111c-of-the-aktg-the-german-stock-corporation-act-with-the-objective-of-europe-wide-distribution/ 2021-07-05T11:39:20+01:00 https://www.epigenomics.com/de/release-according-to-article-111c-of-the-aktg-the-german-stock-corporation-act-with-the-objective-of-europe-wide-distribution/ 2021-07-05T11:40:08+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-4/ 2021-07-19T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-4/ 2021-07-19T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-29/ 2021-07-21T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-29/ 2021-07-21T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-vorstand-und-aufsichtsrat-empfehlen-annahme-des-freiwilligen-offentlichen-ubernahmeangebots/ 2021-07-27T15:47:41+01:00 https://www.epigenomics.com/de/%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8bepigenomics-ag-veroffentlicht-finanzergebnisse-fur-die-ersten-sechs-monate-2021/ 2021-08-10T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-execution-of-a-biobank-sale-agreement-and-update-of-guidance/ 2021-08-16T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-reduction-of-principal-amount-of-planned-mandatory-convertible-bond-to-up-to-eur-16-5-million-and-of-conversion-price-to-eur-1-10-per-share/ 2021-08-19T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-wertpapierprospekt-fur-die-begebung-einer-pflichtwandelanleihe-in-hohe-von-bis-zu-eur-165-mio-durch-die-bafin-gebilligt/ 2021-08-23T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-30/ 2021-08-26T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-30/ 2021-08-26T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-31/ 2021-08-31T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-31/ 2021-08-31T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-32/ 2021-09-01T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-32/ 2021-09-01T23:00:00+01:00 https://www.epigenomics.com/de/neue-studie-zeigt-dass-blutbasiertes-testen-mit-epi-procolonr-eine-wirksame-methode-zur-erhohung-der-darmkrebs-screening-raten-in-medizinisch-unterversorgten-bevolkerungsgruppen-ist/ 2021-09-01T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-platziert-maximale-anzahl-von-pflichtwandelschuldverschreibungen-im-gesamtvolumen-von-eur-165-mio/ 2021-09-12T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-33/ 2021-09-14T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-33/ 2021-09-14T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-34/ 2021-09-15T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-34/ 2021-09-15T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-35/ 2021-09-21T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-35/ 2021-09-21T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-finanzvorstand-albert-weber-verlasst-das-unternehmen/ 2021-10-06T23:00:00+01:00 https://www.epigenomics.com/de/release-according-to-article-111c-of-the-aktg-the-german-stock-corporation-act-with-the-objective-of-europe-wide-distribution-2/ 2021-10-08T13:05:55+01:00 https://www.epigenomics.com/release-according-to-article-111c-of-the-aktg-the-german-stock-corporation-act-with-the-objective-of-europe-wide-distribution-3/ 2021-10-08T13:08:05+01:00 https://www.epigenomics.com/release-according-to-article-111c-of-the-aktg-the-german-stock-corporation-act-with-the-objective-of-europe-wide-distribution-3-2/ 2021-10-08T13:09:28+01:00 https://www.epigenomics.com/de/release-according-to-article-111c-of-the-aktg-the-german-stock-corporation-act-with-the-objective-of-europe-wide-distribution-2-2/ 2021-10-08T13:10:15+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-5/ 2021-10-26T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-5/ 2021-10-26T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-36/ 2021-10-26T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-36/ 2021-10-26T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-37/ 2021-10-27T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-37/ 2021-10-27T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-38/ 2021-11-02T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-38/ 2021-11-02T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlicht-finanzergebnisse-fur-die-ersten-neun-monate-2021/ 2021-11-11T12:59:49+00:00 https://www.epigenomics.com/de/%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8baufsichtsrat-der-epigenomics-ag-beruft-dr-andrew-lukowiak-als-president-und-chief-scientific-officer/ 2021-11-17T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-74/ 2021-11-17T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-74/ 2021-11-17T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-39/ 2021-11-30T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-39/ 2021-11-30T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-75/ 2021-12-02T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-75/ 2021-12-02T22:00:00+00:00 https://www.epigenomics.com/de/%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8baufsichtsrat-der-epigenomics-ag-beruft-jens-ravens-als-chief-financial-officer/ 2021-12-13T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-76/ 2022-01-20T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-76/ 2022-01-20T22:00:00+00:00 https://www.epigenomics.com/de/aufsichtsrat-der-epigenomics-ag-bestatigt-greg-hamilton-als-vorstandsvorsitzenden-fur-die-entwicklung-des-epi-procolon-next-gen-darmkrebs-fruherkennungstests/ 2022-01-23T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-40/ 2022-01-25T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-40/ 2022-01-25T22:00:00+00:00 https://www.epigenomics.com/de/%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8bepigenomics-ag-veroffentlicht-finanzergebnisse-fur-das-geschaftsjahr-2021/ 2022-03-23T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-7/ 2022-04-26T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-7/ 2022-04-26T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-41/ 2022-04-26T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-41/ 2022-04-26T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-77/ 2022-05-09T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-77/ 2022-05-09T23:00:00+01:00 https://www.epigenomics.com/de/%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8bepigenomics-ag-veroffentlicht-finanzergebnisse-fur-das-erste-quartal-2022/ 2022-05-10T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-78/ 2022-05-10T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-40-section-1-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-78/ 2022-05-10T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-8/ 2022-07-18T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-8/ 2022-07-18T23:00:00+01:00 https://www.epigenomics.com/de/%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8bepigenomics-ag-veroffentlicht-finanzergebnisse-fur-die-ersten-sechs-monate-2022/ 2022-08-09T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-verlustanzeige-nach-%c2%a7-92-abs-1-aktg-7/ 2022-08-14T23:00:00+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-71/ 2022-08-16T13:51:52+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-73/ 2022-08-16T13:51:52+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-70/ 2022-08-16T13:51:52+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-68/ 2022-08-16T13:51:53+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-69/ 2022-08-16T13:51:53+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-72/ 2022-08-16T13:51:53+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-english-8/ 2022-08-16T13:51:53+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-64/ 2022-08-16T13:51:54+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-65/ 2022-08-16T13:51:54+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-66/ 2022-08-16T13:51:54+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-67/ 2022-08-16T13:51:54+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-60/ 2022-08-16T13:51:56+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-61/ 2022-08-16T13:51:56+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-english-7/ 2022-08-16T13:51:56+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-62/ 2022-08-16T13:51:56+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-63/ 2022-08-16T13:51:56+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-3/ 2022-08-16T13:51:57+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-4/ 2022-08-16T13:51:57+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-english/ 2022-08-16T13:51:57+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-2/ 2022-08-16T13:51:57+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch/ 2022-08-16T13:51:57+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-59/ 2022-08-16T13:51:57+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-5/ 2022-08-16T13:51:58+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-6/ 2022-08-16T13:51:58+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-10/ 2022-08-16T13:52:00+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-9/ 2022-08-16T13:52:00+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-8/ 2022-08-16T13:52:00+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-7/ 2022-08-16T13:52:00+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-14/ 2022-08-16T13:52:01+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-12/ 2022-08-16T13:52:01+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-english-2/ 2022-08-16T13:52:01+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-11/ 2022-08-16T13:52:01+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-13/ 2022-08-16T13:52:01+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-15/ 2022-08-16T13:52:02+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-english-3/ 2022-08-16T13:52:02+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-16/ 2022-08-16T13:52:02+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-17/ 2022-08-16T13:52:03+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-21/ 2022-08-16T13:52:04+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-20/ 2022-08-16T13:52:04+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-19/ 2022-08-16T13:52:04+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-18/ 2022-08-16T13:52:04+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-24/ 2022-08-16T13:52:05+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-english-4/ 2022-08-16T13:52:05+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-25/ 2022-08-16T13:52:05+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-22/ 2022-08-16T13:52:05+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-23/ 2022-08-16T13:52:05+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-english-5/ 2022-08-16T13:52:06+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-26/ 2022-08-16T13:52:06+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-27/ 2022-08-16T13:52:07+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-31/ 2022-08-16T13:52:08+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-32/ 2022-08-16T13:52:08+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-33/ 2022-08-16T13:52:08+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-34/ 2022-08-16T13:52:08+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-29/ 2022-08-16T13:52:08+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-30/ 2022-08-16T13:52:08+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-28/ 2022-08-16T13:52:08+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-36/ 2022-08-16T13:52:09+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-37/ 2022-08-16T13:52:09+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-38/ 2022-08-16T13:52:09+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-35/ 2022-08-16T13:52:09+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-39/ 2022-08-16T13:52:10+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-40/ 2022-08-16T13:52:11+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-43/ 2022-08-16T13:52:12+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-42/ 2022-08-16T13:52:12+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-41/ 2022-08-16T13:52:12+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-46/ 2022-08-16T13:52:13+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-47/ 2022-08-16T13:52:13+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-english-6/ 2022-08-16T13:52:13+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-45/ 2022-08-16T13:52:13+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-44/ 2022-08-16T13:52:13+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-50/ 2022-08-16T13:52:14+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-49/ 2022-08-16T13:52:14+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-48/ 2022-08-16T13:52:14+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-51/ 2022-08-16T13:52:15+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-58/ 2022-08-16T13:52:16+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-57/ 2022-08-16T13:52:16+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-56/ 2022-08-16T13:52:16+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-55/ 2022-08-16T13:52:16+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-54/ 2022-08-16T13:52:16+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-53/ 2022-08-16T13:52:16+01:00 https://www.epigenomics.com/dgap-dd-epigenomics-ag-deutsch-52/ 2022-08-16T13:52:16+01:00 https://www.epigenomics.com/de/epigenomics-ag-schliest-kapitalerhohung-erfolgreich-ab-3/ 2022-08-31T12:11:32+01:00 https://www.epigenomics.com/de/epigenomics-ag-plant-ausgabe-einer-pflichtwandelschuldverschreibung-in-hohe-von-bis-zu-eur-1815-mio/ 2022-08-31T12:11:32+01:00 https://www.epigenomics.com/de/epigenomics-ag-abschluss-von-biobank-sale-agreement-und-anhebung-der-prognose/ 2022-08-31T12:11:32+01:00 https://www.epigenomics.com/de/epigenomics-ag-herabsetzung-des-nennbetrags-der-geplanten-pflichtwandelanleihe-auf-bis-zu-eur-165-mio-und-des-wandlungspreises-auf-eur-110-je-aktie/ 2022-08-31T12:11:32+01:00 https://www.epigenomics.com/de/epigenomics-ag-kapitalherabsetzung-und-weitere-ermachtigung-zur-ausgabe-von-wandelschuldschreibungen-mit-backstop-investor-geplant/ 2022-08-31T12:11:33+01:00 https://www.epigenomics.com/de/epigenomics-ag-gibt-pflichtwandelschuldverschreibung-in-hohe-von-bis-zu-eur-55-mio-aus/ 2022-08-31T12:11:33+01:00 https://www.epigenomics.com/de/staatliche-us-krankenversicherung-centers-for-medicare-medicaid-services-veroffentlichen-negative-ncd-erstattungsentscheidung-fur-epi-procolon/ 2022-08-31T12:11:33+01:00 https://www.epigenomics.com/de/epigenomics-ag-platziert-pflichtwandelschuldverschreibung-in-voller-hohe-von-eur-55-mio/ 2022-08-31T12:11:33+01:00 https://www.epigenomics.com/de/epigenomics-ag-pruft-ma-optionen/ 2022-08-31T12:11:33+01:00 https://www.epigenomics.com/de/epigenomics-ag-beschliest-kapitalerhohung-mit-bezugsrecht-der-aktionare-4/ 2022-08-31T12:11:33+01:00 https://www.epigenomics.com/de/epigenomics-ag-schliest-kapitalerhohung-erfolgreich-ab/ 2022-08-31T12:11:34+01:00 https://www.epigenomics.com/de/centers-for-medicare-medicaid-services-eroffnen-ncd-prufungsprozess-fur-epi-procolon/ 2022-08-31T12:11:34+01:00 https://www.epigenomics.com/de/epigenomics-ag-beschliest-kapitalerhohung-im-rahmen-einer-privatplatzierung/ 2022-08-31T12:11:34+01:00 https://www.epigenomics.com/de/epigenomics-ag-schliest-kapitalerhohung-erfolgreich-ab-2/ 2022-08-31T12:11:34+01:00 https://www.epigenomics.com/de/epigenomics-ag-staatliche-us-krankenversicherung-centers-for-medicare-medicaid-services-veroffentlichen-negativen-ncd-erstattungsvorschlag-fur-epi-procolon/ 2022-08-31T12:11:34+01:00 https://www.epigenomics.com/de/epigenomics-ag-beendet-zusammenarbeit-mit-chinesischem-lizenzpartner-und-veroffentlicht-erwartete-umsatzsteigerung-fur-2019/ 2022-08-31T12:11:35+01:00 https://www.epigenomics.com/de/epigenomics-ag-cms-akzeptiert-epigenomics-antrag-auf-ncd-uberprufung-2/ 2022-08-31T12:11:35+01:00 https://www.epigenomics.com/de/epigenomics-ag-chinesisches-patent-reexamination-department-erklart-epigenomics-patentanspruche-fur-septin9-teilweise-fur-ungultig/ 2022-08-31T12:11:35+01:00 https://www.epigenomics.com/de/epigenomics-ag-beschliest-kapitalerhohung-mit-bezugsrecht-der-aktionare-2/ 2022-08-31T12:11:35+01:00 https://www.epigenomics.com/de/epigenomics-ag-legt-bezugspreis-von-eur-111-pro-neue-aktie-fest-2/ 2022-08-31T12:11:35+01:00 https://www.epigenomics.com/de/epigenomics-ag-legt-bezugspreis-von-eur-186-pro-neue-aktie-fest-2/ 2022-08-31T12:11:37+01:00 https://www.epigenomics.com/de/epigenomics-ag-schliest-kapitalerhohung-erfolgreich-ab-bruttoemissionserlos-von-223-mio-eur/ 2022-08-31T12:11:37+01:00 https://www.epigenomics.com/de/epigenomics-ag-verlustanzeige-nach-%c2%a7-92-abs-1-aktg-4/ 2022-08-31T12:11:38+01:00 https://www.epigenomics.com/de/epigenomics-ag-american-cancer-society-veroffentlicht-aktualisierte-richtlinien-zur-darmkrebsvorsorge/ 2022-08-31T12:11:38+01:00 https://www.epigenomics.com/de/epigenomics-ag-centers-for-medicare-medicaid-services-cms-veroffentlichen-vorlaufige-kataloggebuhr-von-usd-192-fur-epigenomics-darmkrebs-test-epi-procolonr/ 2022-08-31T12:11:38+01:00 https://www.epigenomics.com/de/epigenomics-ag-plant-kapitalerhohung-mit-bezugsrecht-der-aktionare-wesentlicher-aktionar-nimmt-an-geplanter-kapitalerhohung-teil/ 2022-08-31T12:11:38+01:00 https://www.epigenomics.com/de/epigenomics-ag-erhoht-kapital-im-rahmen-einer-privatplatzierung-von-neuen-aktien-2/ 2022-08-31T12:11:39+01:00 https://www.epigenomics.com/de/epigenomics-ag-blitz-f16-83-gmbh-plant-ubernahmeangebot-fur-epigenomics-ag-2/ 2022-08-31T12:11:39+01:00 https://www.epigenomics.com/de/epigenomics-ag-reduziert-prognose-fur-das-geschaftsjahr-2017/ 2022-08-31T12:11:39+01:00 https://www.epigenomics.com/de/epigenomics-ag-verlustanzeige-nach-%c2%a7-92-abs-1-aktg-5/ 2022-08-31T12:11:39+01:00 https://www.epigenomics.com/de/epigenomics-ag-erhoht-kapital-im-rahmen-einer-privatplatzierung-von-neuen-aktien/ 2022-08-31T12:11:39+01:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-schliest-strategische-lizenz-und-entwicklungsvereinbarung-mit-biochain-fur-innovativen-blutbasierten-lungenkrebstest-fur-china-ab/ 2022-08-31T12:11:40+01:00 https://www.epigenomics.com/de/epigenomics-ag-erhalt-fda-zulassung-fur-epi-procolonr/ 2022-08-31T12:11:40+01:00 https://www.epigenomics.com/de/epigenomics-ag-erhoht-kapital-im-rahmen-einer-privatplatzierung-von-neuen-aktien-4/ 2022-08-31T12:11:40+01:00 https://www.epigenomics.com/de/aufsichtsrat-der-epigenomics-ag-ernennt-gregory-hamilton-zum-vorsitzenden-des-vorstands-3/ 2022-08-31T12:11:40+01:00 https://www.epigenomics.com/de/epigenomics-ag-erhoht-kapital-im-rahmen-einer-privatplatzierung-von-neuen-aktien-3/ 2022-08-31T12:11:40+01:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-passt-ausblick-fur-2015-nach-fda-antwortschreiben-an/ 2022-08-31T12:11:41+01:00 https://www.epigenomics.com/de/epigenomics-ag-fda-fordert-weitere-daten-vor-zulassung-von-epigenomics-bluttest-zum-darmkrebs-screening-2/ 2022-08-31T12:11:41+01:00 https://www.epigenomics.com/de/epigenomics-ag-erhebt-einspruch-gegen-fda-forderung-nach-zusatzlichen-daten/ 2022-08-31T12:11:41+01:00 https://www.epigenomics.com/de/epigenomics-ag-erhalt-nachricht-von-der-fda-uber-den-stand-der-entscheidung-uber-die-marktzulassung-fur-epi-procolonr/ 2022-08-31T12:11:41+01:00 https://www.epigenomics.com/de/epigenomics-epi-procolonr-erreicht-in-admit-studie-eine-teilnehmerrate-von-995-2/ 2022-08-31T12:11:43+01:00 https://www.epigenomics.com/de/ad-hoc-mitteilung-nach-%c2%a7-15-wphg-epigenomics-ag-kundigt-kapitalerhohung-von-bis-eur-5-mio-an/ 2022-08-31T12:11:43+01:00 https://www.epigenomics.com/de/epigenomics-ag-epigenomics-ag-platziert-maximale-anzahl-neuer-aktien-aus-bezugsrechtskapitalerhohung/ 2022-08-31T12:11:43+01:00 https://www.epigenomics.com/de/ad-hoc-mitteilung-gemas-%c2%a7-15-wphg-epigenomics-partner-biochain-schliest-klinische-validierungsstudie-zur-cfda-zulassung-von-epi-procolonr-in-china-erfolgreich-ab/ 2022-08-31T12:11:44+01:00 https://www.epigenomics.com/de/ad-hoc-mitteilung-gemas-%c2%a7-15-wphg-epigenomics-erhalt-antwortschreiben-von-der-fda-zu-ihrem-blutbasierten-test-zur-fruherkennung-von-darmkrebs-epi-procolonr-in-dem-weitere-daten-vor-einer-zula/ 2022-08-31T12:11:44+01:00 https://www.epigenomics.com/de/ad-hoc-mitteilung-gemas-%c2%a7-15-wphg-epigenomics-ag-fuhrt-kapitalerhohung-in-hohe-von-usd-53-mio-mit-ihrem-strategischen-vertriebspartner-biochain-durch/ 2022-08-31T12:11:44+01:00 https://www.epigenomics.com/de/ad-hoc-mitteilung-gemas-%c2%a7-15-wphg-epigenomics-und-biochain-geben-zulassung-von-epi-procolonr-in-china-bekannt/ 2022-08-31T12:11:44+01:00 https://www.epigenomics.com/de/ad-hoc-meldung-gemas-%c2%a7-15-wphg-epigenomics-ag-begibt-wandelschuldverschreibungen-in-hohe-von-eur-500-000/ 2022-08-31T12:11:45+01:00 https://www.epigenomics.com/de/ad-hoc-meldung-gemas-%c2%a7-15-wphg-epigenomics-ag-gibt-einberufung-des-expertengremiums-der-fda-zu-epi-procolonr-bekannt/ 2022-08-31T12:11:45+01:00 https://www.epigenomics.com/de/ad-hoc-meldung-gemas-%c2%a7-15-wphg-epigenomics-ag-gibt-wandelschuldverschreibungen-in-hohe-von-bis-zu-eur-268-mio-aus/ 2022-08-31T12:11:45+01:00 https://www.epigenomics.com/de/ad-hoc-meldung-gemas-%c2%a7-15-wphg-epigenomics-ag-setzt-wandlungspreis-fest/ 2022-08-31T12:11:45+01:00 https://www.epigenomics.com/de/ad-hoc-meldung-gemas-%c2%a7-15-wphg-epigenomics-ag-platziert-maximale-anzahl-von-wandelschuldverschreibungen/ 2022-08-31T12:11:45+01:00 https://www.epigenomics.com/de/ad-hoc-mitteilung-gemas-%c2%a7-15-wphg-epigenomics-ag-fda-expertengremium-gibt-empfehlung-fur-epigenomics-blutbasierten-test-zur-fruherkennung-von-darmkrebs/ 2022-08-31T12:11:45+01:00 https://www.epigenomics.com/de/ad-hoc-meldung-gemas-%c2%a7-15-wphg-epigenomics-und-polymedco-unterzeichnen-kommerzialisierungsvereinbarung-fur-epi-procolonr-fur-den-nordamerikanischen-markt/ 2022-08-31T12:11:46+01:00 https://www.epigenomics.com/de/ad-hoc-meldung-gemas-%c2%a7-15-wphg-epigenomics-begibt-neue-aktien-an-biochain-investition-folgt-vereinbarung-zu-einer-umfangreichen-strategischen-kooperation-in-china/ 2022-08-31T12:11:46+01:00 https://www.epigenomics.com/de/ad-hoc-meldung-gemas-%c2%a7-15-wphg-epigenomics-und-biochain-unterzeichnen-vereinbarung-uber-eine-umfangreiche-strategische-zusammenarbeit-in-china/ 2022-08-31T12:11:46+01:00 https://www.epigenomics.com/de/ad-hoc-mitteilung-nach-%c2%a715-wphg-epigenomics-ag-kundigt-kapitalerhohung-an/ 2022-08-31T12:11:46+01:00 https://www.epigenomics.com/de/ad-hoc-mitteilung-nach-%c2%a715-wphg-epigenomics-ag-verkundet-erfolgreichen-abschluss-einer-kapitalerhohung-durch-ausgabe-neuer-aktien-in-einer-privatplatzierung/ 2022-08-31T12:11:46+01:00 https://www.epigenomics.com/de/korrekturmitteilung-ad-hoc-mitteilung-nach-%c2%a715-wphg-korrektur-der-meldung-epigenomics-ag-kundigt-kapitalerhohung-an/ 2022-08-31T12:11:46+01:00 https://www.epigenomics.com/de/ad-hoc-meldung-gemas-%c2%a7-15-wphg-epigenomics-ag-begibt-wandelschuldverschreibungen-in-hohe-von-eur-500-000-an-ya-global-master-spv-ltd/ 2022-08-31T12:11:47+01:00 https://www.epigenomics.com/de/ad-hoc-meldung-gemas-%c2%a7-15-wphg-epigenomics-ag-sichert-finanzierung-von-bis-zu-eur-5-mio/ 2022-08-31T12:11:49+01:00 https://www.epigenomics.com/de/epigenomics-ag-kapitalherabsetzung-im-verhaltnis-von-4-1-geplant/ 2022-09-08T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-capital-reduction-planned-at-a-ratio-of-4-1/ 2022-09-08T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-anhebung-der-ergebnisprognose-fur-das-laufende-geschaftsjahr-2022-aufgrund-von-wahrungsgewinnen-und-geringeren-studienkosten/ 2022-09-18T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-raise-of-earnings-guidance-for-the-current-fiscal-year-2022-due-to-currency-gains-and-lower-study-costs/ 2022-09-18T23:00:00+01:00 https://www.epigenomics.com/de/%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8bepigenomics-initiiert-prospektive-multi-zentrische-klinische-studie-fur-blutbasierten-darmkrebs-test-epi-procolon-next-gen/ 2022-09-18T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-9/ 2022-10-16T23:00:00+01:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-10/ 2022-10-16T23:00:00+01:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-42/ 2022-11-01T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-42/ 2022-11-01T22:00:00+00:00 https://www.epigenomics.com/de/%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8b%e2%80%8bepigenomics-ag-veroffentlicht-finanzergebnisse-fur-die-ersten-neun-monate-2022/ 2022-11-08T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-10/ 2022-12-05T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-release-according-to-article-41-of-the-wphg-the-german-securities-trading-act-with-the-objective-of-europe-wide-distribution-9/ 2022-12-05T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlicht-leistungsdaten-zum-next-gen-test/ 2022-12-13T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-lizenziert-protein-biomarker-technologie-fur-blutbasierten-darmkrebs-test/ 2022-12-13T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-veroffentlicht-leistungsdaten-zum-next-gen-test/ 2022-12-13T22:00:00+00:00 https://www.epigenomics.com/epigenomics-releases-performance-data-on-next-generation-test-2/ 2022-12-13T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-heino-von-prondzynski-kauf/ 2022-12-13T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-heino-von-prondzynski-buy/ 2022-12-13T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ecx-de-2018-results-highlight-strong-underlying-growth-momentum/ 2022-12-14T07:44:14+00:00 https://www.epigenomics.com/epigenomics-ecx-de-key-catalysts-to-fuel-growth-throughout-2019/ 2022-12-14T07:44:14+00:00 https://www.epigenomics.com/epigenomics-ecx-de-q3-milestone-completion-triggers-more-commercial-momentum/ 2022-12-14T07:44:16+00:00 https://www.epigenomics.com/epigenomics-ecx-de-strong-tailwinds-expected-from-epi-proliver/ 2022-12-14T07:44:17+00:00 https://www.epigenomics.com/epigenomics-ecx-de-liver-boost-less-dependency-on-epicolon/ 2022-12-14T07:44:18+00:00 https://www.epigenomics.com/de/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-43/ 2022-12-18T22:00:00+00:00 https://www.epigenomics.com/epigenomics-ag-veroffentlichung-gemas-%c2%a7-40-abs-1-wphg-mit-dem-ziel-der-europaweiten-verbreitung-43/ 2022-12-18T22:00:00+00:00 https://www.epigenomics.com/de/epigenomics-hauptversammlung-ceo-wirbt-fur-ubernahmeangebot/ 2022-12-19T14:57:50+00:00 https://www.epigenomics.com/de/epigenomics-ag-wirtschaftssenatorin-cornelia-yzer-eroffnet-epigenomics-neue-firmenzentrale-in-berlin-schoneberg/ 2022-12-19T14:57:51+00:00 https://www.epigenomics.com/de/epigenomics-ag-aktion-zur-darmkrebs-fruherkennung-von-epigenomics-und-dem-institut-fur-medizinische-diagnostik-im-rahmen-der-health-week-ein-voller-erfolg/ 2022-12-19T14:57:51+00:00 https://www.epigenomics.com/de/epigenomics-ag-systematische-wissenschaftliche-uberprufung-unterstreicht-nutzen-von-bluttest-epi-procolonr-bei-der-darmkrebserkennung/ 2022-12-19T14:57:51+00:00